The global Sunflower Oil Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product and Service ((Reagents, Kits, and Consumables), Instruments, Software and Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing and Next-generation Sequencing, DNA Microarray, Others), By Disease (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample ((Blood, Serum, and Plasma), Urine, Others), End User (Diagnostic Laboratories, Hospitals and Clinics, Academic Research Institutes, Others)
Technological advancements and innovations in diagnostic methods are playing a pivotal role in propelling the market forward. The continuous development of novel diagnostic technologies, including molecular diagnostics, immunoassays, and point-of-care testing, enhances the accuracy, speed, and efficiency of detecting infectious diseases. The rising incidence of diseases such as COVID-19, HIV/AIDS, tuberculosis, hepatitis, and various bacterial and viral infections are fueling the demand for effective diagnostic tools and are driving investments in research and development initiatives aimed at improving diagnostic capabilities. Ongoing innovations are improving the sensitivity, specificity, and multiplexing capabilities of these tests, enabling faster and more accurate detection of various infectious agents. Additionally, Emerging technologies like next-generation sequencing (NGS) and CRISPR-based diagnostics are becoming increasingly prominent in infectious disease diagnostics.
The market report analyses the leading companies in the industry including Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Cepheid Inc., DiaSorin Spa, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN N.V., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Vela Diagnostics, and Others.
A significant shift towards decentralized testing methods that enable rapid and convenient diagnostic outcomes at or near the patient's location are fueling the demand. The increasing demand for POC testing arises from its advantages in expediting diagnoses, especially in remote or resource-limited settings where access to centralized laboratories may be limited. Additionally, advancements in POC testing technologies are leading to the development of highly sensitive and specific assays that offer reliability comparable to traditional laboratory-based tests.
The rising prevalence of infectious diseases worldwide, including persistent ailments such as HIV/AIDS, tuberculosis, hepatitis, and emerging health crises like the COVID-19 pandemic are propelling the market. Additionally, the urgency to curb the spread of these diseases and improve patient outcomes are fueling the market's growth by fostering collaborations, encouraging technological advancements. Further, resource-limited settings where rapid identification of infectious agents is critical for timely intervention and containment are compelling the adoption of accurate diagnostic solutions.
Technological advancements enabling the identification of specific genetic markers, facilitating precision diagnostics are driving the market. Healthcare providers and stakeholders are seeking to minimize adverse effects, optimize therapeutic interventions, and enhance disease management by adopting personalized diagnostic approaches. Additionally, the growing importance of personalized medicine in infectious disease diagnostics, offering opportunities for innovation, collaboration, and the development of highly specific and efficient diagnostic solutions are driving the market growth.
The Infectious Disease Diagnostics Market is analyzed across (Reagents, Kits, and Consumables), Instruments and Software and Services. Reagents, Kits, and Consumables is poised to register the fastest growth. These reagents, kits, and consumables play a fundamental role in facilitating accurate and precise infectious disease diagnoses. Reagents, which encompass biochemical substances used in laboratory tests, aid in detecting and quantifying infectious agents or biomarkers, forming the backbone of many diagnostic assays. Kits designed for infectious disease diagnostics offer packaged solutions containing necessary reagents, controls, and instructions, streamlining the testing process for laboratories and healthcare facilities. These kits cater to specific infections or pathogens, providing standardized tools for efficient and reliable testing. They ensure proper handling and processing of samples, contributing significantly to the accuracy and reliability of diagnostic procedures.
The Infectious Disease Diagnostics Market is analyzed across various testing types including Laboratory Testing and PoC Testing. Of these, PoC Testing held a significant market share in 2024. PoC tests are designed to be user-friendly, rapid, and easily deployable, enabling quick diagnosis and timely clinical decision-making, particularly in urgent or remote settings where immediate results are critical. These tests encompass a wide array of formats, including lateral flow assays, molecular tests, and immunoassays, among others. They cater to various infectious diseases, providing rapid detection of pathogens or specific biomarkers indicative of infections. PoC Testing aids in swift diagnosis, enabling prompt initiation of appropriate treatments or interventions, ultimately enhancing patient care and outcomes. The convenience and speed offered by PoC Testing significantly reduce the turnaround time for obtaining diagnostic results, facilitating faster decision-making by healthcare professionals.
By Product and Service
By Type of Testing
By Technology
By Disease
By Sample
By End User
By Region
*List not exhaustive
Infectious Disease Diagnostics Market Outlook 2025
1 Market Overview
1.1 Introduction to the Infectious Disease Diagnostics Market
1.2 Scope of the Study
1.3 Research Objective
1.3.1 Key Market Scope and Segments
1.3.2 Players Covered
1.3.3 Years Considered
2 Executive Summary
2.1 2023 Infectious Disease Diagnostics Industry- Market Statistics
3 Market Dynamics
3.1 Market Drivers
3.2 Market Challenges
3.3 Market Opportunities
3.4 Market Trends
4 Market Factor Analysis
4.1 Porter’s Five Forces
4.2 Market Entropy
4.2.1 Global Infectious Disease Diagnostics Market Companies with Area Served
4.2.2 Products Offerings Global Infectious Disease Diagnostics Market
5 COVID-19 Impact Analysis and Outlook Scenarios
5.1.1 Covid-19 Impact Analysis
5.1.2 Post-COVID-19 Scenario- Low Growth Case
5.1.3 Post-COVID-19 Scenario- Reference Growth Case
5.1.4 Post-COVID-19 Scenario- Low Growth Case
6 Global Infectious Disease Diagnostics Market Trends
6.1 Global Infectious Disease Diagnostics Revenue (USD Million) and CAGR (%) by Type (2018-2030)
6.2 Global Infectious Disease Diagnostics Revenue (USD Million) and CAGR (%) by Applications (2018-2030)
6.3 Global Infectious Disease Diagnostics Revenue (USD Million) and CAGR (%) by Regions (2018-2030)
7 Global Infectious Disease Diagnostics Market Revenue (USD Million) by Type, and Applications (2018-2022)
7.1 Global Infectious Disease Diagnostics Revenue (USD Million) by Type (2018-2022)
7.1.1 Global Infectious Disease Diagnostics Revenue (USD Million), Market Share (%) by Type (2018-2022)
7.2 Global Infectious Disease Diagnostics Revenue (USD Million) by Applications (2018-2022)
7.2.1 Global Infectious Disease Diagnostics Revenue (USD Million), Market Share (%) by Applications (2018-2022)
8 Global Infectious Disease Diagnostics Development Regional Status and Outlook
8.1 Global Infectious Disease Diagnostics Revenue (USD Million) By Regions (2018-2022)
8.2 North America Infectious Disease Diagnostics Revenue (USD Million) by Type, and Application (2018-2022)
8.2.1 North America Infectious Disease Diagnostics Revenue (USD Million) by Country (2018-2022)
8.2.2 North America Infectious Disease Diagnostics Revenue (USD Million) by Type (2018-2022)
8.2.3 North America Infectious Disease Diagnostics Revenue (USD Million) by Applications (2018-2022)
8.3 Europe Infectious Disease Diagnostics Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)
8.3.1 Europe Infectious Disease Diagnostics Revenue (USD Million), by Country (2018-2022)
8.3.2 Europe Infectious Disease Diagnostics Revenue (USD Million) by Type (2018-2022)
8.3.3 Europe Infectious Disease Diagnostics Revenue (USD Million) by Applications (2018-2022)
8.4 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)
8.4.1 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) by Country (2018-2022)
8.4.2 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) by Type (2018-2022)
8.4.3 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) by Applications (2018-2022)
8.5 South America Infectious Disease Diagnostics Revenue (USD Million), by Type, and Applications (2018-2022)
8.5.1 South America Infectious Disease Diagnostics Revenue (USD Million), by Country (2018-2022)
8.5.2 South America Infectious Disease Diagnostics Revenue (USD Million) by Type (2018-2022)
8.5.3 South America Infectious Disease Diagnostics Revenue (USD Million) by Applications (2018-2022)
8.6 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)
8.6.1 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) by Country (2018-2022)
8.6.2 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) by Type (2018-2022)
8.6.3 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) by Applications (2018-2022)
9 Company Profiles
10 Global Infectious Disease Diagnostics Market Revenue (USD Million), by Type, and Applications (2023-2030)
10.1 Global Infectious Disease Diagnostics Revenue (USD Million) and Market Share (%) by Type (2023-2030)
10.1.1 Global Infectious Disease Diagnostics Revenue (USD Million), and Market Share (%) by Type (2023-2030)
10.2 Global Infectious Disease Diagnostics Revenue (USD Million) and Market Share (%) by Applications (2023-2030)
10.2.1 Global Infectious Disease Diagnostics Revenue (USD Million), and Market Share (%) by Applications (2023-2030)
11 Global Infectious Disease Diagnostics Development Regional Status and Outlook Forecast
11.1 Global Infectious Disease Diagnostics Revenue (USD Million) By Regions (2023-2030)
11.2 North America Infectious Disease Diagnostics Revenue (USD Million) by Type, and Applications (2023-2030)
11.2.1 North America Infectious Disease Diagnostics Revenue (USD) Million by Country (2023-2030)
11.2.2 North America Infectious Disease Diagnostics Revenue (USD Million), by Type (2023-2030)
11.2.3 North America Infectious Disease Diagnostics Revenue (USD Million), Market Share (%) by Applications (2023-2030)
11.3 Europe Infectious Disease Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)
11.3.1 Europe Infectious Disease Diagnostics Revenue (USD Million), by Country (2023-2030)
11.3.2 Europe Infectious Disease Diagnostics Revenue (USD Million), by Type (2023-2030)
11.3.3 Europe Infectious Disease Diagnostics Revenue (USD Million), by Applications (2023-2030)
11.4 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) by Type, and Applications (2023-2030)
11.4.1 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million), by Country (2023-2030)
11.4.2 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million), by Type (2023-2030)
11.4.3 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million), by Applications (2023-2030)
11.5 South America Infectious Disease Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)
11.5.1 South America Infectious Disease Diagnostics Revenue (USD Million), by Country (2023-2030)
11.5.2 South America Infectious Disease Diagnostics Revenue (USD Million), by Type (2023-2030)
11.5.3 South America Infectious Disease Diagnostics Revenue (USD Million), by Applications (2023-2030)
11.6 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)
11.6.1 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million), by Region (2023-2030)
11.6.2 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million), by Type (2023-2030)
11.6.3 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million), by Applications (2023-2030)
12 Methodology and Data Sources
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Sources
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
List of Tables
Table 1 Market Segmentation Analysis
Table 2 Global Infectious Disease Diagnostics Market Companies with Areas Served
Table 3 Products Offerings Global Infectious Disease Diagnostics Market
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Infectious Disease Diagnostics Revenue (USD Million) And CAGR (%) By Type (2018-2030)
Table 8 Global Infectious Disease Diagnostics Revenue (USD Million) And CAGR (%) By Applications (2018-2030)
Table 9 Global Infectious Disease Diagnostics Revenue (USD Million) And CAGR (%) By Regions (2018-2030)
Table 10 Global Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Table 11 Global Infectious Disease Diagnostics Revenue Market Share (%) By Type (2018-2022)
Table 12 Global Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Table 13 Global Infectious Disease Diagnostics Revenue Market Share (%) By Applications (2018-2022)
Table 14 Global Infectious Disease Diagnostics Market Revenue (USD Million) By Regions (2018-2022)
Table 15 Global Infectious Disease Diagnostics Market Share (%) By Regions (2018-2022)
Table 16 North America Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Table 17 North America Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Table 18 North America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Table 19 Europe Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Table 20 Europe Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Table 21 Europe Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Table 22 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Table 23 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Table 24 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Table 25 South America Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Table 26 South America Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Table 27 South America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Table 28 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Region (2018-2022)
Table 29 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Table 30 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Table 31 Financial Analysis
Table 32 Global Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Table 33 Global Infectious Disease Diagnostics Revenue Market Share (%) By Type (2023-2030)
Table 34 Global Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Table 35 Global Infectious Disease Diagnostics Revenue Market Share (%) By Applications (2023-2030)
Table 36 Global Infectious Disease Diagnostics Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)
Table 37 North America Infectious Disease Diagnostics Revenue (USD)By Country (2023-2030)
Table 38 North America Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Table 39 North America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Table 40 Europe Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Table 41 Europe Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Table 42 Europe Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Table 43 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Table 44 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Table 45 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Table 46 South America Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Table 47 South America Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Table 48 South America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Table 49 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Region (2023-2030)
Table 50 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Region (2023-2030)
Table 51 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Table 52 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Table 53 Research Programs/Design for This Report
Table 54 Key Data Information from Secondary Sources
Table 55 Key Data Information from Primary Sources
List of Figures
Figure 1 Market Scope
Figure 2 Porter’s Five Forces
Figure 3 Global Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Figure 4 Global Infectious Disease Diagnostics Revenue Market Share (%) By Type (2022)
Figure 5 Global Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Figure 6 Global Infectious Disease Diagnostics Revenue Market Share (%) By Applications (2022)
Figure 7 Global Infectious Disease Diagnostics Market Revenue (USD Million) By Regions (2018-2022)
Figure 8 Global Infectious Disease Diagnostics Market Share (%) By Regions (2022)
Figure 9 North America Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Figure 10 North America Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Figure 11 North America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Figure 12 Europe Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Figure 13 Europe Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Figure 14 Europe Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Figure 15 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Figure 16 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Figure 17 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Figure 18 South America Infectious Disease Diagnostics Revenue (USD Million) By Country (2018-2022)
Figure 19 South America Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Figure 20 South America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Figure 21 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Region (2018-2022)
Figure 22 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Type (2018-2022)
Figure 23 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Applications (2018-2022)
Figure 24 Global Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Figure 25 Global Infectious Disease Diagnostics Revenue Market Share (%) By Type (2030)
Figure 26 Global Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Figure 27 Global Infectious Disease Diagnostics Revenue Market Share (%) By Applications (2030)
Figure 28 Global Infectious Disease Diagnostics Market Revenue (USD Million) By Regions (2023-2030)
Figure 29 North America Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Figure 30 North America Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Figure 31 North America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Figure 32 Europe Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Figure 33 Europe Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Figure 34 Europe Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Figure 35 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Figure 36 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Figure 37 Asia Pacific Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Figure 38 South America Infectious Disease Diagnostics Revenue (USD Million) By Country (2023-2030)
Figure 39 South America Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Figure 40 South America Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Figure 41 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Region (2023-2030)
Figure 42 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Region (2023-2030)
Figure 43 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Type (2023-2030)
Figure 44 Middle East and Africa Infectious Disease Diagnostics Revenue (USD Million) By Applications (2023-2030)
Figure 45 Bottom-Up and Top-Down Approaches For This Report
Figure 46 Data Triangulation
By Product and Service
By Type of Testing
By Technology
By Disease
By Sample
By End User
By Region
The Global Infectious Disease Diagnostics Market Size is estimated at $30.7 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.8% to reach $65.5 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Cepheid Inc., DiaSorin Spa, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN N.V., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc, Vela Diagnostics, and Others.
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume